Philip Bejon/Malar J
Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018.Kimenyi KM
Wamae K
Ngoi JM
de Laurent ZR
Ndwiga L
Osoti V
Obiero G
Abdi AI
Bejon P
Ochola-Oyier LI
Malar J, (2022). 21:192
Factors influencing health workers' compliance with outpatient malaria 'test and treat' guidelines during the plateauing performance phase in Kenya, 2014-2016.Amboko B
Stepniewska K
Machini B
Bejon P
Snow RW
Zurovac D
Malar J, (2022). 21:68
The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations.Ndwiga L
Osoti V
Ochwedo KO
Wamae K
Bejon P
Rayner JC
Githinji G
Ochola-Oyier LI
Malar J, (2021). 20:278
Spatial-temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast.Kamau A
Mtanje G
Mataza C
Bejon P
Snow RW
Malar J, (2021). 20:227
Building momentum for malaria vaccine research and development: key considerations.Chitnis CE
Schellenberg D
Vekemans J
Asturias EJ
Bejon P
Collins KA
Crabb BS
Herrera S
Laufer M
Rabinovich NR
Roestenberg M
Shearley A
Tinto H
Wentworth M
O'Brien K
Alonso P
Malar J, (2020). 19:421
Trends in health workers' compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010-2016.Amboko B
Stepniewska K
Macharia PM
Machini B
Bejon P
Snow RW
Zurovac D
Malar J, (2020). 19:406
Malaria infection, disease and mortality among children and adults on the coast of Kenya.Kamau A
Mtanje G
Mataza C
Mwambingu G
Mturi N
Mohammed S
Ong'ayo G
Nyutu G
Nyaguara A
Bejon P
Snow RW
Malar J, (2020). 19:210
Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial.Talisuna AO
Oburu A
Githinji S
Malinga J
Amboko B
Bejon P
Jones C
Snow RW
Zurovac D
Malar J, (2017). 16:46
Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.Ochola-Oyier LI
Okombo J
Wagatua N
Ochieng J
Tetteh KK
Fegan G
Bejon P
Marsh K
Malar J, (2016). 15:261
Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.Kangoye DT
Noor A
Midega J
Mwongeli J
Mkabili D
Mogeni P
Kerubo C
Akoo P
Mwangangi J
Drakeley C
Marsh K
Bejon P
Njuguna P
Malar J, (2016). 15:213
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.Hodgson SH
Douglas AD
Edwards NJ
Kimani D
Elias SC
Chang M
Daza G
Seilie AM
Magiri C
Muia A
Juma EA
Cole AO
Rampling TW
Anagnostou NA
Gilbert SC
Hoffman SL
Draper SJ
Bejon P
Ogutu B
Marsh K
Hill AV
Murphy SC
Malar J, (2015). 14:33
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.Vekemans J
Marsh K
Greenwood B
Leach A
Kabore W
Soulanoudjingar S
Asante KP
Ansong D
Evans J
Sacarlal J
Bejon P
Kamthunzi P
Salim N
Njuguna P
Hamel MJ
Otieno W
Gesase S
Schellenberg D
Clinical Trials Partnership Committee
Malar J, (2011). 10:221
Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.Lievens M
Aponte JJ
Williamson J
Mmbando B
Mohamed A
Bejon P
Leach A
Malar J, (2011). 10:222
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui SM
Bejon P
Osier FH
Bull PC
Marsh K
Malar J, (2009). 8:242
Incorporating a quiz into informed consent processes: qualitative study of participants' reactions.Molyneux S
Gikonyo C
Marsh V
Bejon P
Malar J, (2007). 6:145
